Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1170.00 32.70 (2.88%)

54.77% Gain from 52W Low

48,286 NSE+BSE Volume

NSE 14 May, 2025 10:17 AM (IST)

14,347.6

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Alivus Life Sciences Ltd. is on 15 May 2025 for the purpose of Audited Results & Final Dividend See details

Alivus Life Sciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Alivus Life Sciences Ltd. on BSE

Load latest

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

121 Votes:

Buy 75.21%

Sell 13.22%

Hold 11.57%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >